Changes in activated T cells in the blood correlate with disease activity in multiple sclerosis

Archives of Neurology

Volumn 57, Issue 8, 2000, Pages 1183-1189

  Khoury, Samia J ^a,b   Guttmann, Charles R G ^b   Orav, E John ^c   Kikinis, Ron ^b   Jolesz, Frenc A ^b   Weiner, Howard L ^b  

^a Center for Neurologic Diseases   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CELL SURFACE MARKER; DIPEPTIDYL PEPTIDASE IV; GADOLINIUM; INTERLEUKIN 2 RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ADULT; ANTIGEN EXPRESSION; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DISABILITY; DISEASE ACTIVITY; FEMALE; HUMAN; HUMAN CELL; MALE; MULTIPLE SCLEROSIS; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RELAPSE; REMISSION; SCORING SYSTEM; T LYMPHOCYTE ACTIVATION;

EID: 0033898154     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.57.8.1183     Document Type: Article

References (48)

1. Immunologic mechanisms and therapy in multiple sclerosis
2. Immunological aspects of demyelinating diseases
3. Loss of suppressor T cells in active multiple sclerosis: Analysis with monoclonal antibodies
4. In vivo activated T lymphocytes in the peripheral blood and cerebrospinal fluid of patients with multiple sclerosis
5. Selective loss of a subset of T helper cells in active multiple sclerosis
6. Selective loss of the suppressor-inducer T-cell subset in progressive multiple sclerosis: Analysis with anti-2H4 monoclonal antibodies
7. +) T cells in multiple sclerosis
8. Immunoregulatory T cells and lymphocytotoxic antibodies in multiple sclerosis: Weekly analysis over a six-month period
9. T-lymphocyte subpopulations in peripheral blood of patients with multiple sclerosis, patients with other neurological diseases and healthy controls
10. +) T cells in multiple sclerosis cerebrospinal fluid
11. Multiple sclerosis: In relapsing patients. Immune functions vary with disease activity as assessed by MRI
12. Correlation of immunological studies and disease progression in chronic progressive multiple sclerosis
13. Absence of a correlation between T lymphocyte subsets and clinical activity in relapsing-remitting multiple sclerosis
14. Suppressor T cells in family members of patients with multiple sclerosis
15. Rating neurologic impairment in multiple sclerosis: An Expanded Disability Status Scale (EDSS)
16. Defining the clinical course of multiple sclerosis: Results of an international survey
17. Quantitative follow-up of patients with multiple sclerosis using MRI: Technical aspects
18. Quantitative follow-up of patients with multiple sclerosis using MRI: Reproducibility
19. Routine quantitative analysis of brain and cerebrospinal fluid spaces with MR imaging
20. 4D connected component labelling applied to quantitative analysis of MS lesion temporal development
21. Longitudinal data analysis using generalized linear models
22. MS: A CNS and systemic autoimmune disease
23. Decreased autologous mixed lymphocyte reaction in multiple sclerosis
24. Interleukin-1 corrects the defective autologous mixed lymphocyte response in multiple sclerosis
25. + cell lines from patients with progressive multiple sclerosis
26. Decreased HLA-DR antigen expression on monocytes causes impaired suppressor cell activity in multiple sclerosis
27. Changes in serum levels of ICAM and TNF-R correlate with disease activity in multiple sclerosis
28. Association between tumor necrosis factor-α and disease progression in patients with multiple sclerosis
29. + T cells is mediated by interferon-gamma and is defective in chronic progressive multiple sclerosis
30. + T cells via CD40 ligand
31. Elevated interleukin-12 in progressive multiple sclerosis correlates with disease activity and is normalized by pulse cyclophosphamide therapy
32. Cytokine secretion of myelin basic protein reactive T cells in patients with multiple sclerosis
33. Comparison of MS clinical phenotypes using conventional and magnetization transfer MRI
34. Low and high affinity cellular receptors for interleukin 2: Implications for the level of Tac antigens
35. Induction and upregulation by interleukin 2 of high-affinity interleukin 2 receptors on thymocytes and T cells
36. The interleukin-2 receptor: Functional consequences of its bimolecular structure
37. Only high-affinity receptors for interleukin 2 mediate internalization of ligand
38. Immunoregulatory molecules and IL 2 receptors identified in multiple sclerosis brain
39. + T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells
40. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting intedeukin 2 production
41. CD26; A surface protease involved in T cell activation
42. Characterization of adenosine deaminase binding to human CD26 on T cells and its biologic role in immune response
43. CD26, let it cut or cut it down
44. Remarkable increase in CD26-positive T cells in patients with human T lymphotropic virus type I (HTLV-I) associated myelopathy
45. Expression and functional role of 1F7 (CD26) antigen on peripheral blood and synovial fluid T cells in rheumatoid arthritis patients
46. Biochemical characterization of CD26 (dipeptidyl peptidase IV): Functional comparison of distinct epitopes recognized by various anti-CD26 monoclonal antibodies
47. Adhesion molecule expression on cerebrospinal fluid T lymphocytes: Evidence for common recruitment mechanisms in multiple sclerosis, aseptic meningitis, and normal controls